Effect of Platelet-Activating Factor on Barrier Function of ARPE-19 Cells

References

• AdijantoJ, PhilpNJ. Cultured primary human fetal retinal pigment epithelium (hfRPE) as a model for evaluating RPE metabolism. Exp Eye Res. 2014;126:77–84. doi:10.1016/j.exer.2014.01.015.24485945
   PubMed Web of Science ®Google Scholar
• ChenM, MuckersieE, RobertsonM, FraczekM, ForresterJV, XuH. Characterization of a spontaneous mouse retinal pigment epithelial cell line B6-RPE07. Investigative Opthalmology & Visual Science. 2008;49(8):3699–3706. doi:10.1167/iovs.07-1522.
   PubMed Web of Science ®Google Scholar
• WittchenES, HartnettME. The small GTPase Rap1 is a novel regulator of RPE cell barrier function. Invest Ophthalmol Vis Sci. 2011;52(10):7455–7463. doi:10.1167/iovs.11-7295.21873678
   PubMed Web of Science ®Google Scholar
• DingX, PatelM, ChanCC. Molecular pathology of age-related macular degeneration. Prog Retin Eye Res. 2009;28(1):1–18. doi:10.1016/j.preteyeres.2008.10.001.19026761
   PubMed Web of Science ®Google Scholar
• FukudaAI, BreuelKF. Effect of platelet activating factor on embryonic development and implantation in the mouse. Human Reproduction. 1996;11(12):2746–2749.9021383
   PubMed Web of Science ®Google Scholar
• NilssonG, MetcalfeDD, TaubDD. Demonstration that platelet-activating factor is capable of activating mast cells and inducing a chemotactic response. Immunology. 2000;99(2):314–319.10692052
   PubMed Web of Science ®Google Scholar
• BraquetP, Paubert-BraquetM, BourgainRH, BussolinoF, HosfordD. PAF/cytokine auto-generated feedback networks in microvascular immune injury: consequences in shock, ischemia and graft rejection. J Lipid Mediat. 1989;1(2):75–112.2519889
   PubMedGoogle Scholar
• Kasperska-ZajacA, BrzozaZ, RogalaB. Platelet activating factor as a mediator and therapeutic approach in bronchial asthma. Inflammation. 2008;31(2):112–120. doi:10.1007/s10753-007-9056-9.18193345
   PubMed Web of Science ®Google Scholar
• Hu-LoweDD, ChenE, ZhangL, et al. Targeting activin receptor-like kinase 1 inhibits angiogenesis and tumorigenesis through a mechanism of action complementary to anti-VEGF therapies. Cancer Res. 2011;71(4):1362–1373. doi:10.1158/0008-5472.CAN-10-1451.21212415
   PubMed Web of Science ®Google Scholar
• HondaZ, IshiiS, ShimizuT. Platelet-activating factor receptor. J Biochem. 2002;131(6):773–779. doi:10.1093/oxfordjournals.jbchem.a00316412038971
   PubMed Web of Science ®Google Scholar
• HeY-G, WangH, ZhaoB, et al. Functional analysis of platelet-activating factor in the retinal pigment epithelial cells and choroidal endothelial cells. Curr Eye Res. 2009;34(11):957–965. doi:10.3109/02713680903231135.19958112
   PubMed Web of Science ®Google Scholar
• ZhangH, YangY, TakedaA, et al. A novel platelet-activating factor receptor antagonist inhibits choroidal neovascularization and subretinal fibrosis. PLoS One. 2013;8(6):e68173. doi:10.1371/journal.pone.0068173.23826375
   PubMed Web of Science ®Google Scholar
• KnezevicII, PredescuSA, NeamuRF, et al. Tiam1 and Rac1 are required for platelet-activating factor-induced endothelial junctional disassembly and increase in vascular permeability. J Biol Chem. 2009;284(8):5381–5394. doi:10.1074/jbc.M808958200.19095647
   PubMed Web of Science ®Google Scholar
• ChenY, YangP, LiF, KijlstraA, ProostP. The effects of Th17 cytokines on the inflammatory mediator production and barrier function of ARPE-19 cells. PLoS One. 2011;6(3):e18139. doi:10.1371/journal.pone.0018139.21479174
   PubMed Web of Science ®Google Scholar
• AblonczyZ, DahroujM, TangPH, et al. Human retinal pigment epithelium cells as functional models for the RPE in vivo. Investigative Opthalmology & Visual Science. 2011;52(12):8614–8620. doi:10.1167/iovs.11-8021.
   PubMed Web of Science ®Google Scholar
• AblonczyZ, CrossonCE. VEGF modulation of retinal pigment epithelium resistance. Exp Eye Res. 2007;85(6):762–771. doi:10.1016/j.exer.2007.08.010.17915218
   PubMed Web of Science ®Google Scholar
• AbeT, SuganoE, SaigoY, TamaiM. Interleukin-1β and Barrier Function of Retinal Pigment Epithelial Cells (ARPE-19): aberrant Expression of Junctional Complex Molecules. Investigative Opthalmology & Visual Science. 2003;44(9):4097–4104. doi:10.1167/iovs.02-0867
   PubMed Web of Science ®Google Scholar
• PengS, RahnerC, RizzoloLJ. Apical and basal regulation of the permeability of the retinal pigment epithelium. Investigative Opthalmology & Visual Science. 2003;44(2):808–817. doi:10.1167/iovs.02-0473
   PubMed Web of Science ®Google Scholar
• BuzzaMS, Netzel-ArnettS, Shea-DonohueT, et al. Membrane-anchored serine protease matriptase regulates epithelial barrier formation and permeability in the intestine. Proc Natl Acad Sci U S A. 2010;107(9):4200–4205. doi:10.1073/pnas.0903923107.20142489
   PubMed Web of Science ®Google Scholar
• MiuraY, KlettnerA, RoiderJ. VEGF antagonists decrease barrier function of retinal pigment epithelium in vitro: possible participation of intracellular glutathione. Invest Ophthalmol Vis Sci. 2010;51(9):4848–4855. doi:10.1167/iovs.09-4699.20435596
   PubMed Web of Science ®Google Scholar
• McKayBS, IrvingPE, SkumatzCHRISTINEMB, BurkeJM. Cell–Cell Adhesion Molecules and the Development of an Epithelial Phenotype in Cultured Human Retinal Pigment Epithelial Cells. Exp Eye Res. 1997;65(5):661–671. doi:10.1006/exer.1997.0374.9367646
   PubMed Web of Science ®Google Scholar
• XuLF, XuC, MaoZQ, TengX, MaL, SunM. Disruption of the F-actin cytoskeleton and monolayer barrier integrity induced by PAF and the protective effect of ITF on intestinal epithelium. Arch Pharm Res. 2011;34(2):245–251. doi:10.1007/s12272-011-0210-4.21380808
   PubMed Web of Science ®Google Scholar
• BoccellinoM, CamussiG, GiovaneA, et al. Platelet-Activating Factor Regulates Cadherin-Catenin Adhesion System Expression and β-Catenin Phosphorylation during Kaposi’s Sarcoma Cell Motility. The American Journal of Pathology. 1997;65(5):661–671.
   Google Scholar
• GhassemifarR, LaiCM, RakoczyPE. VEGF differentially regulates transcription and translation of ZO-1alpha+ and ZO-1alpha- and mediates trans-epithelial resistance in cultured endothelial and epithelial cells. Cell Tissue Res. 2006;323(1):117–125. doi:10.1007/s00441-005-0046-7.16163490
   PubMed Web of Science ®Google Scholar
• Casals-StenzelJ, MuacevicG, WeberKH. Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor. J Pharm Exp Therapeutics. 1987;241(3):974–981.
   PubMed Web of Science ®Google Scholar
• DoiK, OkamotoK, NegishiK, et al. Attenuation of folic acid-induced renal inflammatory injury in platelet-activating factor receptor-deficient mice. Am j Pathol. 2006;168(5):1413–1424. doi:10.2353/ajpath.2006.050634.16651609
   PubMed Web of Science ®Google Scholar
• SchurrMJ, FabianTC, CroceMA, GeraciSA, ProctorKG. Unexpected action of platelet activating factor antagonism after fluid resuscitation from traumatic shock. Surgery. 1997;121(5):493–500. doi:10.1016/s0039-6060(97)90102-1.9142146
   PubMed Web of Science ®Google Scholar
• DyerKD, PercopoCM, XieZ, et al. Mouse and human eosinophils degranulate in response to platelet-activating factor (PAF) and lysoPAF via a PAF-receptor-independent mechanism: evidence for a novel receptor. J Immunol. 2010;184(11):6327–6334. doi:10.4049/jimmunol.0904043.20421642
   PubMed Web of Science ®Google Scholar
• DengM, GuoH, TamJW, et al. Platelet-activating factor (PAF) mediates NLRP3-NEK7 inflammasome induction independently of PAFR. J Exp Med. 2019;216(12):2838–2853. doi:10.1084/jem.20190111.31558613
   PubMed Web of Science ®Google Scholar